★ Daily Intelligence Briefings (DIBs)Biotechnology & Healthcare Evolving COVID Variants May Render Current Treatments Obsolete, Drive Need for New Round of Therapeutics The COVID-19 omicron variant has diminished the efficacy of the US's most prominent antibody treatments. As the genome of this virus constantly…McAlinden Research PartnersJanuary 4, 2022
★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerBiotechnology & HealthcarePolitics & Policy While we Await a Vaccine, COVID Therapeutic Developments Could Boost Biotech Stocks President Trump's bout of COVID-19 launched countless headlines regarding the some of the leading experimental treatments he'd be receiving - therapeutics…McAlinden Research PartnersOctober 13, 2020
★ Daily Intelligence Briefings (DIBs)Biotechnology & Healthcare Gene Editing Skyrockets into November on New CRISPR Breakthroughs New research on CRISPR techniques that could provide treatments and improved diagnostics for several major viruses and other medical conditions…McAlinden Research PartnersNovember 13, 2019
★ Daily Intelligence Briefings (DIBs)Biotechnology & Healthcare Digital Therapeutics Bring Additional Disruption to Health Care The prevalence of chronic diseases combined with their sky-high price tags is drawing interest to digital therapeutics (DTx), a new…McAlinden Research PartnersOctober 21, 2019